22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/15/22 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
10 | |
| 09/14/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/12/22 | 8-K | Current report filing |
|
   |
4 |
| 09/12/22 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/07/22 | 8-K | Current report filing |
|
|
3 |
| 09/02/22 | S-3 | Registration statement for specified transactions by certain issuers |
|
18 | |
| 09/02/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/02/22 | 8-K/A | Current report filing |
|
|
4 |
| 08/09/22 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 |
